Wall Street Zen Upgrades Mettler-Toledo International (NYSE:MTD) to “Buy”

Mettler-Toledo International (NYSE:MTD) was upgraded by Wall Street Zen from a “hold” rating to a “buy” rating in a note issued to investors on Saturday.

Other research analysts also recently issued reports about the company. Evercore ISI boosted their price objective on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a research note on Tuesday, October 7th. Morgan Stanley assumed coverage on Mettler-Toledo International in a research note on Tuesday, December 2nd. They issued an “equal weight” rating and a $1,550.00 price target on the stock. Stifel Nicolaus raised their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a “buy” rating in a research report on Monday, November 10th. The Goldman Sachs Group assumed coverage on shares of Mettler-Toledo International in a research note on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price objective for the company. Finally, Citigroup boosted their target price on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a research report on Monday, November 10th. Six research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Mettler-Toledo International currently has a consensus rating of “Hold” and a consensus price target of $1,441.67.

Mettler-Toledo International Stock Performance

Shares of NYSE MTD opened at $1,411.83 on Friday. The company’s 50 day moving average price is $1,420.77 and its 200-day moving average price is $1,318.67. Mettler-Toledo International has a 52-week low of $946.69 and a 52-week high of $1,525.17. The company has a market capitalization of $28.84 billion, a P/E ratio of 35.21, a price-to-earnings-growth ratio of 4.20 and a beta of 1.41.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, topping the consensus estimate of $10.62 by $0.53. The company had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $997.36 million. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. Mettler-Toledo International’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period in the prior year, the company posted $10.21 earnings per share. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. Analysts forecast that Mettler-Toledo International will post 42.71 earnings per share for the current year.

Insider Buying and Selling

In related news, insider La Guerroniere Marc De sold 6,880 shares of Mettler-Toledo International stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $1,450.00, for a total value of $9,976,000.00. Following the completion of the sale, the insider owned 187 shares of the company’s stock, valued at approximately $271,150. This trade represents a 97.35% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Shawn Vadala sold 1,895 shares of the company’s stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $1,455.52, for a total transaction of $2,758,210.40. Following the transaction, the chief financial officer owned 5,288 shares in the company, valued at approximately $7,696,789.76. The trade was a 26.38% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 19,565 shares of company stock worth $28,683,737 over the last quarter. Corporate insiders own 0.77% of the company’s stock.

Hedge Funds Weigh In On Mettler-Toledo International

Several large investors have recently added to or reduced their stakes in the business. Versant Capital Management Inc raised its stake in shares of Mettler-Toledo International by 42.1% in the third quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock worth $33,000 after purchasing an additional 8 shares during the last quarter. SJS Investment Consulting Inc. boosted its position in shares of Mettler-Toledo International by 2,700.0% during the third quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 27 shares during the last quarter. NewSquare Capital LLC grew its holdings in Mettler-Toledo International by 94.4% during the second quarter. NewSquare Capital LLC now owns 35 shares of the medical instruments supplier’s stock worth $41,000 after buying an additional 17 shares in the last quarter. MV Capital Management Inc. raised its position in Mettler-Toledo International by 50.0% in the 2nd quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock valued at $42,000 after buying an additional 12 shares during the last quarter. Finally, Root Financial Partners LLC bought a new position in Mettler-Toledo International during the 3rd quarter valued at $42,000. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.